Hepatoprotective effect of infliximab, an anti-TNF-alpha agent, on carbon tetrachloride-induced hepatic fibrosis.
Bahcecioglu IH; Koca SS; Poyrazoglu OK; Yalniz M; Ozercan IH; Ustundag B; Sahin K; Dagli AF; Isik A; Inflammation, 2008, vol. 31, issue 4, p 215, ISSN 03603997. ISBN 03603997.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef